Ann: 2018 AGM Presentation, page-46

Hi Pixi. Sold the last stock a couple of weeks back, only because I needed the cash elsewhere, but obviously glad I did. I ran out of time. Took a huge loss. I fell for the other uses for PBT2 to max shareholders value BS. I still like the idea of metal chelation in neurodegeneration, but Prana have a good safe chelator here IMO and it is disappointing they have not taken it into other non neurodebgeneration fields in the 4+ years since the IMAGINE trial finished. Even delayed cerebral ischemia (DCI) in brain injury is a possibility. Non transferrin bound iron(NTBI) is a big problem in many indications, but whatever happens they need to complete the P1 safety trials. That is not so far away. Unlike some here I don't see Prana going broke, with no debt and a funded trial underway, assuming a good safety result and an on time completion.